Leukemia, T-cell, chronic

Search Trials
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)
Status:
Recruiting
Last Changed:
Jan 30, 2019
First Changed:
Feb 24, 2016
Disease(s):
Leukemia, Adult T-Cell
Intervention(s):
IL-15 plus alemtuzumab
Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Status:
Completed
Last Changed:
Aug 22, 2011
First Changed:
Aug 17, 2011
Disease(s):
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
Intervention(s):
CHOP-daclizumab
Anti-Tac for Treatment of Leukemia
Status:
Completed
Last Changed:
Aug 20, 2012
First Changed:
Jan 19, 2000
Disease(s):
HTLV-I Infection
Intervention(s):
daclizumab
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
Status:
Active, not recruiting
Last Changed:
Aug 28, 2018
First Changed:
Dec 16, 2015
Disease(s):
Acute Adult T-Cell Leukemia/Lymphoma
Intervention(s):
Laboratory Biomarker AnalysisNivolumabPharmacogenomic Study
Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
Status:
Not yet recruiting
Last Changed:
Aug 3, 2018
First Changed:
Aug 3, 2018
Disease(s):
Acute T Cell Leukemia
Intervention(s):
RuxolitinibVincristinePrednisone

Connect. Empower. Inspire.